A Johns Hopkins pancreatic cancer vaccine triggered immune responses in 90% of high-risk participants, with some cysts shrinking after vaccination.
A new vaccine for the prevention of pancreatic cancer has shown promise in an early study at Johns Hopkins School of Medicine in Baltimore, Maryland.
A phase 1 trial published in Cancer Discovery, a… [+3807 chars]
A phase 1 trial published in Cancer Discovery, a… [+3807 chars]